In this episode, Dr. Slavin welcomes Dr. Mattie Crutchfield.  They discuss her journey from considering genetic testing to learning she is a PALB2 mutation carrier and how she is taking action to reduce her cancer risk.

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit https://myriad.com/live/ for a list of dates, times, and subjects.

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit https://myriad.com/live/ for a list of dates, times, and subjects.

References for this episode:

https://fenwayhealth.org/the-fenway-institute/education/the-national-lgbtia-health-education-center/

https://transcare.ucsf.edu/guidelines

BRCA care: https://journals.lww.com/greenjournal/Fulltext/2021/12000/Creating_Breast_and_Gynecologic_Cancer_Guidelines.16.aspx#:~:text=As%20breast%20surgery%20often%20leaves,rather%20than%20traditional%20chest%20masculinization.

Free course about teaching LGBTQ+: Healthhttps://mededucation.stanford.edu/courses/teaching-lgbtq-health/

https://fenwayhealth.org/the-fenway-institute/education/advancing-excellence-in-sexual-and-gender-minority-health/train-the-trainer-course/

https://www.kff.org/other/issue-brief/youth-access-to-gender-affirming-care-the-federal-and-state-policy-landscape/

https://www.aclu.org/legislation-affecting-lgbtq-rights-across-country

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit https://myriad.com/live/ for a list of dates, times, and subjects.

References for this episode:

Kerlilowske reference: JCO 2010. https://pubmed.ncbi.nlm.nih.gov/20644098/

Other suggested articles from Dr. Pederson: Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk https://pubmed.ncbi.nlm.nih.gov/32917665/

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit https://myriad.com/live/ for a list of dates, times, and subjects.

References for this episode:
Genome web article: https://www.genomeweb.com/sequencing/early-cancer-detection-li-fraumeni-syndrome-patients-enabled-liquid-biopsy-test

Abstract: https://acmg.planion.com/Web.User/AbstractDet?ACCOUNT=ACMG&CONF=AM22&ssoOverride=OFF&ABSID=12124

CHARM consortium https://charmconsortium.ca/

NCCN Guidelines: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf

Tumor-Based Genetic Testing and Familial Cancer Risk https://pubmed.ncbi.nlm.nih.gov/31570381

https://liftupstudy.org/

https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.1514

In this episode Dr. Slavin welcomes Dr. Judy Garber, Professor of Medicine at Harvard Medical School, Chief of Division of Cancer Genetics and Prevention at the Dana Farber Institute, and Susan F. Smith Chair. Together, they discuss the OlympiA study and outcomes that have influenced industry guidelines.

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit myriad-oncology.com/myriad-oncology-live for a list of dates, times, and subjects.

References for this episode:

https://genesight.com/for-clinicians/clinical-studies/

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit myriad-oncology.com/myriad-oncology-live for a list of dates, times, and subjects.

References for this episode:
https://ocrahope.org/2021/05/highlights-2021-virtual-annual-meeting-of-sgo/https://www.cancernetwork.com/conference/sgo

List of accepted abstracts from 23rd Annual American Society of Breast Surgeons https://www.breastsurgeons.org/meeting/2022/https://www.breastsurgeons.org/meeting/2022/docs/2022_Official_Proceedings_ASBrS.pdf

Kurian et al paper. https://jamanetwork.com/journals/jama/article-abstract/2600457

Highlights From the Miami Breast Cancer Conference 2022— Co-chair Debu Tripathy, MD, provides an overview of the studies discussed at the meetinghttps://www.medpagetoday.com/meetingcoverage/mbcc-video-pearls/97669Abstracts:https://www.cancernetwork.com/journals/mbcc-suppl/38th-annual-miami-breast-cancer-conference-abstracts-miami-breast-cancer-conference-abstract-supplements

It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs. 

Myriad  Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit myriad-oncology.com/myriad-oncology-live for a list of dates, times, and subjects.

References for this episode:

https://education.asco.org/coursecollection/genetics-and-genomics

COH-Registration now openhttps://www.cityofhope.org/education/health-professional-education/cancer-genomics-education-program/intensive-course-in-cancer-risk-assessment-overview

https://online.stanford.edu/programs/genetics-and-genomics-program

https://www.nurseportfolio.org/

Medical Breast Training Program - Mayo, Cleveland Clinic and Women's College of Toronto : https://ce.mayo.edu/online-education/content/medical-breast-training-program-all-sessions#group-tabs-node-course-default2

https://www.ons.org/learning-libraries/precision-oncology

Diversification of Nurse Practitioner Practice: Genetic Cancer Risk Assessmenthttps://www.sciencedirect.com/science/article/pii/S1555415520301276?via%3Dihub

https://www.duq.edu/academics/schools/nursing/faculty/grants/genomic-competencies-for-nurses-from-theory-to-application-an-online-course#:~:text=This%20professional%20development%20opportunity%20is,year%2C%20each%20spring%20and%20fall.

https://myriad-oncology.com/continuing-education-webinars/

The Myriad Oncology RMS team also leads a series via webinar for GC's and Nurses "Evolving Strategies in Hereditary Cancer". These can be viewed live by invitation. contact your local RMS team to get on that invite list. Also these are available on demand after the live presentation at our webpage https://myriad-oncology.com/continuing-education-webinars/

https://www.gimjournal.org/multimedia/audio#:~:text=GenePod%20is%20the%20podcast%20from,content%20from%20this%20leading%20journal.